Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.960
-0.140 (-3.41%)
At close: Dec 17, 2025, 4:00 PM EST
3.750
-0.210 (-5.30%)
After-hours: Dec 17, 2025, 5:22 PM EST
LIXT Market Cap
LIXT has a market cap or net worth of $22.59 million as of December 17, 2025. Its market cap has increased by 370.60% in one year.
Market Cap
22.59M
Enterprise Value
19.70M
1-Year Change
370.60%
Ranking
Category
Stock Price
$3.96
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $22.59M, a decrease of -52.34%. That is a compound annual growth rate of -13.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 22.60M | 391.30% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |